Compare RACE & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RACE | IDXX |
|---|---|---|
| Founded | 1947 | 1983 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.2B | 55.0B |
| IPO Year | 2015 | 1991 |
| Metric | RACE | IDXX |
|---|---|---|
| Price | $345.37 | $714.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $495.00 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 593.9K | 482.8K |
| Earning Date | 02-10-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | 13.13 | ★ 21.65 |
| EPS | 10.52 | ★ 12.60 |
| Revenue | ★ $8,306,934,179.00 | $4,167,411,000.00 |
| Revenue This Year | $8.84 | $12.15 |
| Revenue Next Year | $5.97 | $8.72 |
| P/E Ratio | ★ $32.84 | $56.77 |
| Revenue Growth | ★ 9.52 | 8.39 |
| 52 Week Low | $344.90 | $356.14 |
| 52 Week High | $519.10 | $769.98 |
| Indicator | RACE | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 30.38 | 56.66 |
| Support Level | $350.66 | $701.49 |
| Resistance Level | $380.42 | $726.41 |
| Average True Range (ATR) | 7.16 | 15.05 |
| MACD | -1.92 | 2.49 |
| Stochastic Oscillator | 0.56 | 83.22 |
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2024, the company sold 13,752 vehicles at an average price over EUR 480,000 with more than 70% of its vehicles being sold to existing Ferrari clients. Eighty-six percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2024, the Europe, Middle East, and Africa region accounted for 47% of revenue, the Americas was 33%, mainland China, Hong Kong, and Taiwan was 8%, and the rest of Asia was 12%.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.